TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia ; volume:24 ; number:1 ; day:10 ; month:9 ; year:2024 ; pages:1-7 ; date:12.2024
BMC pediatrics ; 24, Heft 1 (10.9.2024), 1-7, 12.2024
- Creator
-
Qiu, Kun-yin
Liao, Xiong-yu
Fang, Jian-pei
Zhou, Dun-hua
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12887-024-05053-x
- URN
-
urn:nbn:de:101:1-2411242101109.334847447722
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Qiu, Kun-yin
- Liao, Xiong-yu
- Fang, Jian-pei
- Zhou, Dun-hua
- SpringerLink (Online service)
Other Objects (12)
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Genetic alterations in childhood relapsed high hyperdiploid B-cell acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures
Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia
Inotuzumab Ozogamicin Monotherapy as an Outpatient Salvage Treatment in Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia: Compassionate Access
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Genetic alterations in childhood relapsed high hyperdiploid B-cell acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures
Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia
Inotuzumab Ozogamicin Monotherapy as an Outpatient Salvage Treatment in Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia: Compassionate Access
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Genetic alterations in childhood relapsed high hyperdiploid B-cell acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures
Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia
Inotuzumab Ozogamicin Monotherapy as an Outpatient Salvage Treatment in Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia: Compassionate Access
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study